Stockholders' Equity (Tables)

6 Months Ended

Sep. 30, 2017

Stockholders' Equity Note [Abstract]

Stock Option Transactions Under Stock Option Plans

Stock option activity for the six months ended September 30, 2017 is summarized below:

			Weighted		Weighted		Weighted
			Average		Average		Average
			Per Share		Remaining		Per Share
			Exercise		Life		Intrinsic
	Shares		Price		(Years)		Value
Balance, March 31, 2017		1,165,350	$	4.24		6.64	$	4.86
Granted		80,000		9.71		-		-
Exercised		-		-		-		-
Cancelled/expired		(33,000)		9.62		-		-
Balance, September 30, 2017		1,212,350	$	4.42		6.36	$	5.35
Vested, September 30, 2017		1,040,840	$	4.04		5.92	$	5.74

Summary of Stock Based Compensation Expense Related To Restricted Stock and Option Awards

Stock-based compensation expense related to common stock option awards is recognized over their respective vesting periods and was included in the accompanying condensed consolidated statement of operations as follows:

	Three Months Ended				Six Months Ended
	September 30,				September 30,
	2017		2016		2017		2016
Stock-based compensation expense:
Cost of services	$	-	$	1,227	$	-	$	2,454
General and administrative		195,244		244,814		418,810		491,304
	$	195,244	$	246,041	$	418,810	$	493,758

Warrants Outstanding

Warrants consisted of the following for the six months ended September 30, 2017:

	Weighted
	Average
	Per Share
	Intrinsic		Number of
	Value		Warrants
Outstanding at March 31, 2017	$	4.68		1,970,166
Granted		-		-
Exercised		5.09		(19,000)
Cancelled		-		-
Outstanding at September 30, 2017	$	1.34		1,951,166

					Weighted				Weighted
					Average				Average
Exercise Price Per		Warrants			Remaining		Warrants		Exercise Price Per
Share		Outstanding			Contractual Life		Exercisable		Share
	$4.00-$5.00		169,500	[1]		0.39		169,500		4.46
	$9.00-$10.00		1,781,666	[2]		3.04		1,781,666		9.37
	$4.00-$10.00		1,951,166			2.81		1,951,166	$	8.94

^[1] Such warrants outstanding as of September 30, 2017 comprise warrants issued in October 2009 in connection with the Company’s 10% Senior Subordinated Callable Convertible Notes and warrants issued in January 2013 in connection with the Company’s 9% Senior Subordinated Callable Convertible Promissory Notes. The 2009 warrants have expired as of the date of this Quarterly Report on Form 10-Q. The 2013 warrants may be exercised at an exercise price of $4.50 per share at any time until the end of January 2018. In addition, in November, 2016, in connection with the acquisition of BAHA, the Company issued to Scott Enderby, D.O., a warrant to purchase 24,000 shares of Common Stock at an exercise price of $4.50 per share.

^[2] In July 2014, in connection with the acquisition of SCHC, the Company issued to Stanley Lau, M.D., and Yih Jen Kok, M.D., warrants to purchase up to 100,000 shares of Common Stock (on a post stock-split basis) at an exercise price of $10.00 per share exercisable until July 21, 2018. In February 2015, in consideration of services rendered to the Company, the Company issued to RedChip Companies, Inc. a warrant to purchase up to 10,000 shares of Common Stock (on a post stock-split basis) at an exercise price of $9.00 per share exercisable until February 20, 2018. In connection with NMM’s investments in the Company, in October, 2015 and March 2016, respectively, the Company issued to NMM a stock purchase warrant (the “Series A Warrant”) to purchase up to 1,111,111 shares of Common Stock at an exercise price of $9.00 per share, and a stock purchase warrant (the “Series B Warrant”) to purchase up to 555,555 shares of Common Stock at an exercise price of $10.00 per share. In November, 2016, in connection with a promissory note issued to Liviu Chindris, M.D., which the Company has repaid in full, the Company issued to Dr. Chindris a warrant to purchase up to 5,000 shares of Common Stock at an exercise price of $9.00 per share.

Amount of Shares of Common Stock Reserved

The number of shares of Common Stock reserved for these purposes is as follows as of September 30, 2017:

For warrants outstanding	1,951,166
For stock options outstanding	1,212,350
For debt outstanding and accrued interest	514,093
For preferred stock issued and outstanding	1,666,666
Total	5,344,275